Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer

RJ Cerfolio, AS Bryant, TS Winokur, B Ohja… - The Annals of thoracic …, 2004 - Elsevier
… The change in maxSUV on FDG-PET scan after neoadjuvant therapy holds a near … Lung
cancer is the leading cause of cancer deaths worldwide. More Americans die from lung cancer

Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer

NJ Pastis Jr, TJ Greer, NT Tanner, AE Wahlquist… - Chest, 2014 - Elsevier
early-stage NSCLC, (2) palliative SBRT in the setting of advanced-stage lung cancer, (3)
absence of pretreatment FDG PET-… 3-month follow-up PET-CT scan and (5) FDG PET-CT scan …

Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non–small cell lung cancer

SY Park, A Cho, WS Yu, CY Lee, JG Lee… - Journal of Nuclear …, 2015 - Soc Nuclear Med
stage IA lung cancer, although a large-scale prospective study is needed to confirm our results.
Another application of TLG in stage … in lung cancer surgery, even in early-stage disease. …

Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases

JF Vansteenkiste, SG Stroobants, PR De Leyn… - Chest, 1997 - Elsevier
… We found 13 cases with enlarged MLNs on CT without corresponding FDG uptake on
PET. The PET was correct in 12 of these cases and false negative in 1. This last patient had a …

Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer

S Liao, BC Penney, H Zhang, K Suzuki, Y Pu - Academic radiology, 2012 - Elsevier
Stage IV non–small-cell lung cancer (NSCLC) consists of a heterogeneous group of patients
with different prognoses. We assessed the prognostic value of baseline whole body tumor …

The utility of 18F-FDG PET for suspected recurrent non–small cell lung cancer after potentially curative therapy: impact on management and prognostic stratification

RJ Hicks, V Kalff, MP MacManus, RE Ware… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Early detection is important because salvage therapies are available for localized recurrence.
This study evaluated whether 18 F-FDG PET … with that on FDG PET. Patients with already …

Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

SH Hyun, HK Ahn, H Kim, MJ Ahn, K Park… - European journal of …, 2014 - Springer
… newly diagnosed stage III NSCLC who underwent 18 F-FDG PET/… stage (pathological, if
available, otherwise clinical) based on the new seventh edition of the TNM lung cancer staging

The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre

A Johnson, R Norman, F Piccolo, D Manners - BMC Pulmonary Medicine, 2021 - Springer
… /CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim … staging
in non-small cell lung cancer if FDG-PET/CT was used prior to initial biopsy (FDG-PET/CT First) …

Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis

HJ Im, K Pak, GJ Cheon, KW Kang, SJ Kim… - European journal of …, 2015 - Springer
… (PET)”, “lung cancer”, and “volume”. Inclusion criteria were: 18 F-FDG PET used as an initial
… -small-cell lung cancer (NSCLC); volume measurement of lung cancer; patients who had …

Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer

D Hellwig, A Gröschel, TP Graeter, AP Hellwig… - European journal of …, 2006 - Springer
… for higher SUVs, because the FDG uptake in lung cancer increases at least for 120 min
after injection [29]. As is known from dual time point PET imaging of lung lesions, this results in …